You’re on a run, and your quads feel good, your playlist is solid, and your lung capacity is seemingly endless, so you tack on a few miles more than you’d planned. Next thing you know: shin splints or ...

In idiopathic pulmonary fibrosis (IPF), the trajectory of declining lung function and clinical worsening was less drastic with the use of inhaled treprostinil (Tyvaso), the placeb ...

Understanding how aging reshapes the body and why physical function often declines over time has become a central focus of modern biomedical research. A new Yale School of Medicine (YSM) study, ...

From Olympic gold medals to world records, the Dibaba sisters of Ethiopia have dominated middle- and long-distance running, shaping the sport’s modern era.

More than a year after the second Trump administration began dismantling the US Agency for International Development (USAID), the global health consequences of this unprecedented loss in international ...

The "Checkpoint Inhibitor Refractory Cancer Drugs Market – Growth, Share, Opportunities & Competitive Analysis, 2025 – 2032" report has been added to the Credence Research Inc. offering.

Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily by reducing appetite, helping people eat less and ...

Smoking does more than damage lungs. Orthopaedic expert warns that it can slow bone healing, raise the risk of fractures and complicate recovery after surgeries like knee and hip replacements. No ...

CCS calls for provinces and territories to take immediate action to detect cancers earlier and prevent avoidable deathsOTTAWA, ON, March 11, 2026 /CNW/ - ...

An employee from a private organization undergoes the First Patient Encounter during the PhilHealth YAKAP Caravan. The FPE is an initial, mandatory in-person consultation that establishes a baseline ...

Leerink Global Healthcare Conference 2026 March 11, 2026 9:20 AM EDTCompany ParticipantsJasper Van GrunsvenPeter Griffith - Executive ...

Earnings call Kamada reported 2025 revenues of $180.5M, up 12% YoY, and adjusted EBITDA of $42M, up 23% YoY, both in line with guidance. Management affirmed 2026 guidance for $200M–$205M in revenues ...